Comerica Bank Sells 125 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Comerica Bank lowered its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 0.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,966 shares of the company’s stock after selling 125 shares during the period. Comerica Bank owned 0.08% of Addus HomeCare worth $1,751,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Principal Financial Group Inc. grew its position in shares of Addus HomeCare by 17.5% during the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after purchasing an additional 75,409 shares in the last quarter. Cherry Creek Investment Advisors Inc. bought a new position in Addus HomeCare in the 4th quarter worth about $340,000. Amundi raised its holdings in shares of Addus HomeCare by 185.9% in the 4th quarter. Amundi now owns 9,008 shares of the company’s stock valued at $1,139,000 after acquiring an additional 5,857 shares in the last quarter. Barclays PLC boosted its position in shares of Addus HomeCare by 204.8% during the 3rd quarter. Barclays PLC now owns 43,470 shares of the company’s stock valued at $5,783,000 after acquiring an additional 29,207 shares during the last quarter. Finally, Nordea Investment Management AB grew its holdings in shares of Addus HomeCare by 5.0% during the fourth quarter. Nordea Investment Management AB now owns 35,756 shares of the company’s stock worth $4,548,000 after purchasing an additional 1,697 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on ADUS shares. JMP Securities reiterated a “market outperform” rating and set a $150.00 target price on shares of Addus HomeCare in a research report on Tuesday, April 22nd. Macquarie upped their price objective on Addus HomeCare from $129.00 to $133.00 and gave the stock an “outperform” rating in a report on Thursday. Oppenheimer raised their price objective on Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a report on Friday, January 24th. StockNews.com cut shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Finally, Stephens restated an “overweight” rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. One research analyst has rated the stock with a hold rating, six have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Addus HomeCare presently has an average rating of “Buy” and a consensus target price of $142.57.

Addus HomeCare Stock Up 0.2 %

Shares of ADUS opened at $110.91 on Friday. The stock has a market capitalization of $2.04 billion, a P/E ratio of 25.38, a PEG ratio of 1.41 and a beta of 0.85. Addus HomeCare Co. has a twelve month low of $88.96 and a twelve month high of $136.72. The firm has a fifty day simple moving average of $98.86 and a two-hundred day simple moving average of $114.47.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.09. The company had revenue of $337.71 million for the quarter, compared to analysts’ expectations of $341.66 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare’s quarterly revenue was up 20.3% on a year-over-year basis. During the same period last year, the firm earned $1.21 earnings per share. Sell-side analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.